Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing NaN - NaN of 90
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Germany, United States (TNB-383B)

Recruiting
  • Multiple Myeloma
  • San Francisco, California
  • +14 more
Aug 22, 2022

Multiple Myeloma Trial in Worldwide (Cevostamab, Tocilizumab, Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Duarte, California
  • +7 more
Aug 17, 2022

Multiple Myeloma Trial in United States (Cilta-cel, Lymphodepleting Therapy (Cyclophosphamide and Fludarabine))

Recruiting
  • Multiple Myeloma
  • Cilta-cel
  • Lymphodepleting Therapy (Cyclophosphamide and Fludarabine)
  • Duarte, California
  • +23 more
Aug 1, 2022

Multiple Myeloma Trial in Saint Louis (drug, device, procedure)

Recruiting
  • Multiple Myeloma
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 27, 2022

Multiple Myeloma, Multiple Myeloma in Relapse, Multiple Myeloma With Failed Remission Trial in United States (FOR46)

Completed
  • Multiple Myeloma
  • +2 more
  • San Francisco, California
  • +6 more
Jul 25, 2022

NSCLC, Ovarian Cancer, Fallopian Tube Cancer Trial in United States (CART-TnMUC1, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +5 more
  • CART-TnMUC1
  • +2 more
  • Phoenix, Arizona
  • +9 more
Jul 18, 2022

Multiple Myeloma Trial in Worldwide (BL-8040 1.25mg/kg + G-CSF, Placebo +G-CSF)

Active, not recruiting
  • Multiple Myeloma
  • BL-8040 1.25mg/kg + G-CSF
  • Placebo +G-CSF
  • Los Angeles, California
  • +17 more
Jun 14, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, Durvalumab, Pomalidomide)

Completed
  • Multiple Myeloma
  • Duarte, California
  • +43 more
Jun 9, 2022

Lymphoma, Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Dexamethasone (Oral))

Completed
Has Results
  • Lymphoma
  • Multiple Myeloma
  • Muscle Shoals, Alabama
  • +215 more
May 5, 2022

Multiple Myeloma, Tumor, Plasma Cell, Tumors by Histologic Type Trial in United States (CYNK-001)

Active, not recruiting
  • Multiple Myeloma
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +8 more
May 24, 2022

Acute Myeloid Leukemia, AML, Adult, Multiple Myeloma Trial in United States (FT538, Cyclophosphamide, Fludarabine)

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Denver, Colorado
  • +8 more
May 19, 2022

Multiple Myeloma Trial in Saint Louis (Isatuximab, Bortezomib, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 4, 2022

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus

Active, not recruiting
Has Results
  • Acute Myelogenous Leukemia
  • +10 more
  • Atlanta, Georgia
  • +2 more
Feb 9, 2022

Presentation, Treatment Patterns, and Outcomes in Multiple

Completed
  • Multiple Myeloma
  • No Intervention
  • Little Rock, Arkansas
  • +136 more
Feb 15, 2022

Multiple Myeloma Trial in Worldwide (Elotuzumab, Dexamethasone, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +37 more
Jan 14, 2022

Multiple Myeloma, Lymphoma, Amyloidosis Trial in Worldwide (Ixazomib)

Active, not recruiting
  • Multiple Myeloma
  • +2 more
  • Atlanta, Georgia
  • +23 more
Dec 20, 2021

Lung Cancer, Solid Tumor, Gastric Cancer Trial in Denmark, United States (Pemigatinib, Gemcitabine + Cisplatin, Pembrolizumab)

Completed
  • Lung Cancer
  • +10 more
  • Birmingham, Alabama
  • +19 more
Jan 4, 2022

Multiple Myeloma Trial in United States (Lenalidomide, Elotuzumab, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Atlanta, Georgia
  • +6 more
Dec 17, 2021

Multiple Myeloma Trial in United States (Lenalidomide, lenalidomide, bortezomib and dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Tucson, Arizona
  • +53 more
Dec 8, 2021

Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in United States (oprozomib)

Terminated
  • Multiple Myeloma
  • Waldenstrom Macroglobulinemia
  • Scottsdale, Arizona
  • +18 more
Nov 15, 2021

Cytogenetic Studies in Acute Leukemia and Multiple Myeloma

Active, not recruiting
  • Acute Leukemia
  • +3 more
  • cytogenetic analysis
  • La Jolla, California
  • +136 more
Aug 16, 2021

Multiple Myeloma Trial in Germany, United States (LBH589)

Terminated
Has Results
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +28 more
Jun 22, 2021

Multiple Myeloma Trial in United States (Elotuzumab, Pomalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Mobile, Alabama
  • +21 more
Jun 10, 2021

Multiple Myeloma Trial in Spain, United Kingdom, United States (Venetoclax, Pomalidomide, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • Columbus, Georgia
  • +10 more
Jun 9, 2021

Multiple Myeloma Trial in United States (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Daratumumab, Lenalidomide)

Completed
  • Multiple Myeloma
  • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
  • +4 more
  • Birmingham, Alabama
  • +30 more
Mar 31, 2021